Danaher Announces Quarterly Dividend
Danaher (NYSE: DHR) announced a regular quarterly cash dividend of $0.32 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Danaher (NYSE: DHR) announced a regular quarterly cash dividend of $0.32 per share. The dividend is payable on January 30, 2026 to holders of record on December 26, 2025.
Positive
- $0.32 per share regular quarterly cash dividend declared
- Dividend payable Jan 30, 2026 to record holders on Dec 26, 2025
Negative
- Dividend creates a company cash outflow payable on Jan 30, 2026
Details
News Market Reaction – DHR
On Dec 10, the first trading day after this news, DHR closed 3.22% above the previous close.
Data tracked by StockTitan Argus for the Dec 10 session.
Key Figures
- Quarterly dividend
- $0.32 per share
- Regular quarterly cash dividend declared
- Payment date
- January 30, 2026
- Dividend payable date
- Record date
- December 26, 2025
- Shareholders of record eligible for dividend
Historical Context
-
CEO presentation at Jefferies Global Healthcare Conference with webcast access.
-
Q3 2025 results with revenue and EPS growth and maintained guidance.
-
Scheduling details for upcoming Q3 2025 earnings conference call.
-
Launch of BD‑Tau RUO immunoassay and development of Aβ‑42 test.
-
Board approval of regular quarterly cash dividend of $0.32 per share.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
ABOUT DANAHER
Danaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. Our businesses partner closely with customers to solve many of the most important health challenges impacting patients around the world. Danaher's advanced science and technology - and proven ability to innovate - help enable faster, more accurate diagnoses and help reduce the time and cost needed to sustainably discover, develop and deliver life-changing therapies. Focused on scientific excellence, innovation and continuous improvement, our approximately 63,000 associates worldwide help ensure that Danaher is improving quality of life for billions of people today, while setting the foundation for a healthier, more sustainable tomorrow. Explore more at www.danaher.com.
View original content:https://www.prnewswire.com/news-releases/danaher-announces-quarterly-dividend-302637034.html
SOURCE Danaher Corporation
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.